Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) Completed Phase 4 Trials for Influenza Infection / Flu caused by Influenza Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01196026Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™
NCT01190215Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM
NCT00377611Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
NCT00442975Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status
NCT01730378Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
NCT00363870A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults
NCT02640989Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military